Omer Trivizki discusses promising results of VOY-101, a gene therapy for geographic atrophy, highlighting safety and next steps in ongoing research.
Omer Trivizki, MD, MBA
Advertisement
retina specialist, Deputy Chair at Tel Aviv Medical Center
Articles by Omer Trivizki, MD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
2
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
3
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study
4
Proactive strategies and sustained delivery advance glaucoma care
5
.png "Optometry Times"){kind=logo}
